| Trial registration number
|
NCT05502068 |
Full text link
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05502068
|
First author
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
Valdis Pirags, MD, PhD
|
Contact
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
2022-08-16
|
Recruitment status
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
male or female subjects aged 18 and over
vitamin d level below 30 ng/ml
positive sars-cov-2 test
|
Exclusion criteria
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
patients with mental health problems,
egfr ≤30 ml/min,
vitamin d level ≥ 30 ng/ml,
pregnant women
any other illness or condition that the researcher deemed may interfere with the results
patients who refuse the studies
|
Number of arms
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
Pauls Stradins Clinical University Hospital
|
Inclusion age min
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
Latvia
|
Type of patients
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
No restriction on type of patients
|
Severity scale
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
0: No restriction on type of patients
|
Total sample size
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
102
|
primary outcome
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
Evaluating the effects of a sprayable microemulsion of cholecalciferol on vitamin D levels in the blood of COVID-19 patients
|
Notes
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Aug. 17, 2022, 7 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "nan", "treatment_id": 1370, "treatment_name": "Vitamin d", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|